CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
Sep. 30, 2017	Sep. 30, 2016
Cash flows from operating activities:
Net income	$ 36,916	$ 34,784
Provision (credit) for loan and lease losses	(2,488)	(2,872)
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,768	4,493
Write down of other real estate, net of gain on sale	(192)	(251)
Amortization of core deposit premium and mortgage servicing rights	3,549	6,291
Net amortization of investment securities	8,960	9,326
Share-based compensation	1,120	1,360
Net loss on investment securities	1,640	0
Net gain on sales of residential loans	(3,101)	(5,523)
Proceeds from sales of loans held for sale	249,866	315,348
Originations of loans held for sale	(225,712)	(308,471)
Equity in earnings of unconsolidated subsidiaries	(388)	(456)
Net increase in cash surrender value of bank-owned life insurance	(3,256)	(2,772)
Deferred income taxes	19,984	18,790
Net tax benefits from share-based compensation	614	0
Net change in other assets and liabilities	(15,701)	(1,035)
Net cash provided by operating activities	76,579	69,012
Cash flows from investing activities:
Proceeds from maturities of and calls on investment securities available for sale	128,588	140,258
Proceeds from sales of investment securities available for sale	96,019	0
Purchases of investment securities available for sale	(333,242)	(112,870)
Proceeds from maturities of and calls on investment securities held to maturity	19,455	22,335
Payments to Acquire Held-to-maturity Securities	0	1,644
Net loan proceeds (originations)	(63,835)	(152,906)
Purchases of loan portfolios	(50,725)	(77,702)
Proceeds from sale of other real estate	286	2,850
Proceeds from bank-owned life insurance	2,921	1,506
Purchases of premises and equipment	(4,849)	(3,574)
Net return of capital from unconsolidated subsidiaries	549	528
Contributions to unconsolidated subsidiaries	(4)	(5)
Net proceeds (purchases) from redemption of FHLB stock	5,088	(3,567)
Net cash used in investing activities	(199,749)	(184,791)
Cash flows from financing activities:
Net increase in deposits	319,296	85,139
Net (decrease) increase in short-term borrowings	(135,000)	81,000
Cash dividends paid on common stock	(15,888)	(13,695)
Repurchases of common stock and other related costs	(21,304)	(14,084)
Net proceeds from issuance of common stock and stock option exercises	0	599
Net cash provided by financing activities	147,104	138,959
Net increase in cash and cash equivalents	23,934	23,180
Cash and cash equivalents at beginning of period	84,341	80,194
Cash and cash equivalents at end of period	108,275	103,374
Cash received during the period for:
Income taxes	9,097	6,261
Supplemental disclosure of non-cash investing and financing activities:	7,900	0
Net reclassification of loans to other real estate	154	1,428
Cash received during the period for:
Income taxes	0	1,605
Supplemental disclosure of non-cash investing and financing activities:
Net change in common stock held by directors’ deferred compensation plan	$ 385	$ 537

The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets, and the amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of a finite-lived intangible asset to fair value.

No definition available.